Standard BioTools Inc.
LAB
$1.07
-$0.045-4.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.03M | -34.07M | -26.94M | -45.72M | -32.16M |
| Total Depreciation and Amortization | 4.17M | 3.95M | 6.37M | 4.40M | 5.19M |
| Total Amortization of Deferred Charges | -- | -- | -2.51M | -545.00K | -- |
| Total Other Non-Cash Items | 7.17M | 8.05M | 5.90M | 6.84M | -13.02M |
| Change in Net Operating Assets | -15.60M | 8.02M | -10.69M | -4.03M | -22.50M |
| Cash from Operations | -30.28M | -14.06M | -27.87M | -39.05M | -62.48M |
| Capital Expenditure | -5.05M | -3.38M | -2.26M | -1.94M | -781.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -1.39M | 0.00 | 0.00 | 280.03M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.68M | 30.49M | -28.63M | 52.19M | 38.82M |
| Cash from Investing | 14.63M | 25.73M | -30.88M | 50.26M | 318.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -55.00M | 0.00 | 0.00 | -8.19M |
| Issuance of Common Stock | -- | 525.00K | 68.00K | 1.41M | 72.00K |
| Repurchase of Common Stock | -46.00K | -45.00K | -70.00K | -29.77M | -11.07M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -545.00K |
| Cash from Financing | -46.00K | -54.52M | -2.00K | -28.36M | -19.73M |
| Foreign Exchange rate Adjustments | 357.00K | -267.00K | -408.00K | -89.00K | -21.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.35M | -43.12M | -59.16M | -17.24M | 235.85M |